Samsung Biologics to help Enzolytics advance clinical development of mAbs

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production.

Related Keywords

Incheon ,Inch On Gwangyoksi ,South Korea ,Texas ,United States ,San Francisco ,California ,Gaurav Chandra ,Bioclonetics Immunotherapeutics ,San Francisco Rd Center ,Samsung ,Enzolytics Inc ,Feline Leukemia Virus ,Equine Infectious Anemia Virus ,Inactivated Pepsin Fragment ,Upstream Processing ,Covid 19 ,Pipelines ,Bio Outsourcing ,Cell Lines ,Monoclonal Antibodies ,Shiv ,